Kabra Drugs Ltd vs Torrent Pharmaceuticals Ltd

A side-by-side comparison of Kabra Drugs Ltd (KABRADG) and Torrent Pharmaceuticals Ltd (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Torrent Pharmaceuticals Ltd leads KABRADG vs TORNTPHARM on 9 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

10.30
P/E ratio
78.86
1.73
P/B ratio
20.18
0.00%
Dividend yield
0.76%
₹2.07
EPS
₹63.92

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

-4.40%
Return on equity
27.40%
-7.82%
Return on capital
15.00%
0.00%
EBITDA margin
33.00%
0.00%
Net margin
15.29%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
13.27%
Profit CAGR (3Y)
19.75%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹51 Cr
Market cap
₹1.84L Cr
₹0 Cr
Revenue
₹13,980 Cr
₹-1 Cr
Net profit
₹2,138 Cr
0.02
Debt / equity
1.79
Kabra Drugs Ltd
  • + ["Company is almost debt free."]
  • ["Company has a low return on equity of 7.79% over last 3 years.", "Company has high debtors of 279 days."]
Torrent Pharmaceuticals Ltd
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 19.2 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
Kabra Drugs Ltd full analysis Torrent Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.